Skip to main content
Erschienen in: Journal of Ophthalmic Inflammation and Infection 1/2016

Open Access 01.12.2016 | Original research

Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients

verfasst von: Jin A Choi, Kyu Seop Kim, Younhea Jung, Hae Young Lopilly Park, Chan Kee Park

Erschienen in: Journal of Ophthalmic Inflammation and Infection | Ausgabe 1/2016

Abstract

Background

The aims of this study are to investigate the clinical characteristics of patients with anterior hypertensive uveitis and to compare the characteristics between patients in cytomegalovirus (CMV)-positive and CMV-negative groups in their aqueous humor samples.
Immunocompetent patients (n = 42) with a history of chronic and/or recurrent hypertensive anterior uveitis underwent ophthalmic examination and serological tests. Among the 42 patients with hypertensive anterior uveitis, aqueous humor sampling was performed in 21, and they were analyzed for viral deoxyribonucleic acids using the polymerase chain reaction (PCR).

Results

The average age of the 42 patients with hypertensive anterior uveitis was 57.6 years, and 29 (69.0 %) of the subjects were males. Of the patients, 22 (52.4 %) underwent glaucoma surgery, and the average corneal endothelial cell counts were 1908 cells/mm2. Among the 21 patients who underwent an aqueous sampling, 6 were positive for CMV-DNA, while 15 were negative. The frequency of glaucoma surgery was similar between groups (CMV positive vs. CMV negative, 66.0 vs. 66.0 %, P = 0.701). However, 66.7 % of the CMV-positive group underwent glaucoma tube shunt surgery, whereas 80 % of the CMV-negative group underwent trabeculectomy or received an ExPRESS glaucoma filtration device (Alcon, Fort Worth, TX) for glaucoma surgery (P = 0.095). The corneal endothelial cell counts were significantly lower in the CMV-positive group (CMV positive vs. CMV negative, 1245 ± 560 vs. 1981 ± 387 cells/mm2; P = 0.009).

Conclusions

CMV was found to be an etiological factor in patients with hypertensive anterior uveitis in Korea. Special caution is needed for patients with CMV-induced hypertensive anterior uveitis, considering its adverse effect on the corneal endothelium.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12348-016-0100-5) contains supplementary material, which is available to authorized users.

Background

Herpes viruses are known to play a role in the idiopathic anterior uveitis associated with ocular hypertension [14]. There are three herpes viruses responsible for ocular inflammation; human cytomegalovirus (CMV), herpes simplex virus (HSV)-1, and varicella zoster virus (VZV). CMV has been recognized as a cause of morbidity and mortality, mostly in immunocompromised individuals [3, 4]. Recent reports have shown that CMV infection is an emerging cause of anterior uveitis associated with ocular hypertension in immunocompetent subjects [1, 2, 5, 6]. CMV is also an important cause of corneal endotheliitis, particularly in Asian populations [712]. However, the pathogenesis of CMV-induced anterior uveitis in immunocompetent patients and the systemic and ocular characteristics of the disease are not well understood.
In the present study, we investigated the clinical characteristics of patients with anterior hypertensive uveitis and compared the ocular and systemic characteristics between CMV-positive and CMV-negative patients in their aqueous humor. Finally, we investigated the factors associated with the corneal endothelial cell loss in the hypertensive anterior uveitis patients.

Methods

This was a retrospective review of patients with anterior hypertensive uveitis who were investigated at Seoul St. Mary’s Hospital from March 2009 to June 2014. This study was performed according to the tenets of the Declaration of Helsinki, and the study protocol was approved by the institutional review/ethics boards of the Seoul St. Mary’s Hospital, the Catholic University of Korea (IRB number: KC14RISI0513). All of the patients included in this study met the following criteria: (1) anterior uveitis with keratic precipitates (KPs) and (2) increased intraocular pressure (IOP). Patients with the following were excluded: (1) presence of inflammation in vitreous or retina and (2) presence of corneal endothelial changes for a known cause other than anterior uveitis.
All of the participants underwent a comprehensive ophthalmic examination, including a detailed review of medical and ocular histories, best-corrected visual acuity measurement, slit-lamp biomicroscopy, Goldmann applanation tonometry, specular microscopy using a non-contact specular microscope (Konan Noncon Robo, Konan Medical, Inc., Hyogo, Japan), dilated stereoscopic examination of the optic nerve head and fundus, stereoscopic optic disc photography and red-free retinal nerve fiber layer (RNFL) photography (Nonmyd 7; Kowa Company Ltd., Nagoya, Japan), achromatic automated perimetry using the 24–2 Swedish Interactive Threshold Algorithm Standard program (Humphrey Visual Field (VF) Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA, USA), and optical coherence tomography scans (Cirrus OCT, Carl Zeiss Meditec) to measure peripapillary RNFL thickness. Peripapillary RNFL thickness was determined three times at 256 points around a set diameter (3.4 mm) circle using the fast RNFL program. Only well-focused, well-centered images without eye movement and a signal strength ≥7 were used. A global average RNFL thickness provided by the software was used for the analysis. All of the patients underwent a laboratory work-up (including complete blood count, erythrocyte sedimentation rate analysis, white cell count and differential, blood chemistry) and serologic screening for IgM and IgG anti-CMV, HSV, and VZV.
Among the 42 patients with hypertensive anterior uveitis, aqueous sampling was performed in 21. Using a 30-gauge needle, 100 μL aqueous humor was aspirated under aseptic conditions and subjected to a polymerase chain reaction (PCR) assay for CMV, HSV1, and HSV2 DNA. DNA was extracted from the aqueous humor samples using a QIAamp DNA minikit (Qiagen, Valencia, CA, USA). Quantitative CMV-DNA PCR testing was performed using an AccuPower CMV Quantitative PCR Kit (Bioneer, Daejun, Republic of Korea). For HSV PCR, the HSV 1/2 PCR Kit (Bio-Core, Seoul, Republic of Korea) was used.
Glaucoma was defined as having glaucomatous disc appearance (thinning of neuroretinal rim, peripapillary hemorrhage, or localized pallor) associated with a typical reproducible VF defect evident on standard automated perimetry. A glaucomatous VF defect was defined as a glaucoma hemifield test result outside normal limits and the presence of at least three contiguous points in the pattern deviation plot with P values <5 %, with at least one point associated with a P value <1 % on two consecutive reliable VF examinations.
Patients were classified according to the duration of active intraocular inflammation. Patients with at least 3 months of active intraocular inflammation were considered to have chronic uveitis, and other patients to have recurrent episode of acute uveitis, which was normalized between attacks [2]. Glaucoma treatment was started in a step-wise manner; anti-glaucoma medication (beta-blocker, alpha-2 agonists, topical acetazolamide, and prostaglandin), and finally, glaucoma surgery. Glaucoma surgery was chosen among conventional trabeculectomy/ExPRESS glaucoma filtration device (Alcon Laboratories, Fort Worth, TX, USA) or Ahmed glaucoma valve implant (New World Medical, Inc., Rancho Cucamonga, CA, USA) surgery, considering preoperative IOP and severity of glaucomatous optic disc damage.

Statistical analysis

For independent samples, the non-parametric Mann-Whitney U test and the χ 2 test were used to compare between-group means and percentages. Multivariable analysis was performed using simple and multiple linear regressions for corneal endothelial cell counts according to the presence of CMV-DNA in the aqueous humor. First, we adjusted for age and gender (model 1). Then we adjusted for age, gender, lens status, and history of glaucoma surgery (model 2). A P value <0.05 was considered to statistically significant. All of the statistical analyses were performed using the SPSS software (ver. 14.0 for Windows; SPSS Inc.).

Results

The clinical features of our patients are summarized in Table 1. The average age of the 42 patients with hypertensive anterior uveitis was 57.6 years, and 29 (69.0 %) of the subjects were males. In total, 22 (52.4 %) patients underwent glaucoma surgery, and the mean corneal endothelial cell counts were 1908 cells/mm2.
Table 1
Clinical parameters of 42 patients with hypertensive anterior uveitis
Gender (M/F)
29:13
Age (range), years
57.6 (25–88)
Spherical equivalent, D
−2.6 (−11.25–0.00)
Glaucoma operation,%
22 (52.4 %)
Corneal endothelial cell count, cells/mm2
1908 (625–3067)
Unilaterality
39 (92.9 %)
KPs at baseline examination
28 (67.8 %)
Anterior chamber reaction with 1+ or less
37 (88.1 %)
Severe peripheral anterior synechiae
0 (0.0 %)
Typical feature of P-S syndrome
14 (33.3 %)
Among the 21 patients who underwent aqueous sampling, six were positive for CMV-DNA, whereas 15 were negative (Table 2). The CMV-positive group was significantly younger and more myopic than the CMV-negative group (CMV positive vs. CMV negative: 47.5 ± 14.8 vs. 67.6 ± 11.8 years, P = 0.006; −3.6 ± 4.2 vs. 0.0 ± 1.6 D, P = 0.031). The frequency of glaucoma surgery was similar between the groups (CMV positive vs. CMV negative, 66.0 vs. 66.0 %, P = 0.701). However, 66.7 % of CMV-positive group had an Ahmed glaucoma valve implanted, whereas 80 % of the CMV-negative group underwent trabeculectomy or use of the ExPRESS glaucoma filtration device (P = 0.095). The corneal endothelial cell counts were significantly lower in the CMV-positive group (CMV positive vs. CMV negative: 1245 ± 560 vs. 1981 ± 387 cells/mm2; P = 0.009).
Table 2
Comparisons of clinical and immunologic characteristics in subjects with or without CMV in aqueous humor
Characteristics
CMV-positive subjects n = 6
CMV-negative subjects n = 15
P value
Demographic characteristics
 Male, n (%)
6 (100 %)
13 (86.7 %)
0.500
 Age, years
47.5 ± 14.8
67.6 ± 11.8
0.006
Ocular characteristics
 Initial BCVA
0.65 ± 0.29
0.58 ± 0.29
0.569
 Final BCVA
0.47 ± 0.46
0.52 ± 0.30
0.733
 Spherical equivalent, D
-3.6 ± 4.2
0.0 ± 1.6
0.031
 Axial length, mm
25.7 ± 1.5
24.4 ± 0.7
0.053
 Glaucoma, n (%)
6 (100 %)
13 (86.7 %)
0.347
 Average RNFL thickness, μm
66.2 ± 16.7
77.8 ± 19.1
0.132
 Corneal endothelial cell count, mm2
1245 ± 560
1981 ± 387
0.009
 Unilaterality, n (%)
83.3
80.0
0.684
 KPs at baseline examination, n (%)
83.3
73.3
0.550
 Presence of PAS, n (%)
4 (66.7 %)
5 (33.3 %)
0.331
 Anterior chamber reaction with 1+ or less, n (%)
100.0
92.9
0.714
 Lens status, phakic, n (%)
5 (83.3 %)
5 (33.3 %)
0.055
 Baseline IOP, mmHg
28.83 ± 8.25
22.73 ± 7.86
0.132
 Maximum IOP, mmHg
37.17 ± 8.03
39.53 ± 13.02
0.622
 Final IOP, mmHg
13.3 ± 3.44
13.5 ± 5.05
0.950
Number of anti-glaucoma medication, n
2.67 ± 0.81
2.67 ± 0.81
0.970
Course of uveitis
  
0.544
 Chronic, n (%)
4 (66.7 %)
13 (86.7 %)
 
 Recurrent, n (%)
2 (33.3 %)
2 (13.3 %)
 
Glaucoma operation, n (%)
4 (66.7 %)
10 (66.7 %)
0.701
Choice of glaucoma operation
  
0.095
 Ahmed valve, n (%)
3 (75.0 %)
2 (20.0 %)
 
 Trabeculectomy or ExPRESS, n (%)
1 (25.0 %)
8 (80.0 %)
 
HSV PCR positivity, n (%)
0 (0.0 %)
1 (6.2 %)
0.727
CMV RQ PCR, copies/mL
46,048.8 ± 91,334.5
Negative
n/a
CMV cytomegalovirus, BCVA best-corrected visual acuity, RNFL retinal nerve fiber layer, KP keratic precipitate, PAS peripheral anterior synechiae, n/a not applicable
Table 3 shows the laboratory characteristics of subjects with and without CMV-PCR(+) in the aqueous humor. In the CMV-positive subjects, the percentage of monocytes tended to be lower than in the CMV-negative subjects, with marginal significance (P = 0.055), whereas other parameters did not differ between the groups. The presence of CMV in the aqueous humor was significantly associated with corneal endothelial cell count after controlling for age and gender (P = 0.023), which was maintained after additional adjustment for lens status and history of glaucoma surgery (P < 0.001; Table 4). The clinical information of the 6 CMV+ patients was described in the Additional file 1, and two representative cases with antiviral treatment are discussed.
Table 3
Comparison of laboratory findings in subjects with or without CMV-PCR (+) in aqueous humor
Characteristics
CMV-positive subjects n = 6
CMV-negative subjects n = 15
P value
Complete blood count
 WBC count, cells/μL
7300 ± 900
6,700 ± 1900
0.590
 Seg, %
54.4 ± 8.7
55.9 ± 7.7
0.677
 Lymp, %
35.0 ± 6.6
31.9 ± 7.1
0.424
 Mono, %
6.5 ± 0.7
7.8 ± 1.6
0.055
 Eosinophil, %
3.5 ± 1.8
3.8 ± 3.2
0.970
 Basophil, %
0.6 ± 0.3
0.5 ± 0.2
0.302
 RBC count, 106/μL
5.0 ± 0.5
4.4 ± 0.6
0.059
 Hemoglobin g/dl
15.5 ± 1.4
13.9 ± 2.0
0.070
 Platelet count, 103/μL
247.5 ± 51.0
220.8 ± 58.8
0.329
 ESR, mm/h
10.5 ± 7.6
31.8 ± 32.7
0.283
Blood chemistry
 FBS, mg/dL
103.7 ± 18.7
100.5 ± 44.1
0.519
 AST, IU/L
23.3 ± 3.3
23.6 ± 10.5
0.367
 ALT, IU/L
28.7 ± 10.5
27.2 ± 15.7
0.590
 BUN, mg/dL
15.3 ± 4.7
17.8 ± 6.7
0.261
 Creatinine, mg/dL
0.9 ± 0.1
1.0 ± 0.3
0.971
 GFR, ml/min/1.73 m2
91.1 ± 8.9
79.2 ± 19.1
0.178
 Na, mEq/L
142.3 ± 1.2
141.9 ± 3.2
0.858
 K, mEq/L
4.4 ± 0.4
4.3 ± 0.5
0.914
Immunology
 HSV IgM positivity, n (%)
1 (16.7 %)
0 (0.0 %)
0.273
 HSV IgG, titer, AU/mL
3.3 ± 1.4
6.5 ± 6.8
0.320
 VZV IgM positivity, n (%)
1 (16.7 %)
0 (0.0 %)
0.273
 VZV IgG titer, AU/mL
5.3 ± 3.1
5.0 ± 2.2
1.000
 CMV IgM positivity, n (%)
0 (0.0 %)
0 (0.0 %)
n/a
 CMV IgG titer, AU/mL
54.7 ± 15.3
55.7 ± 16.4
1.000
HSV herpes simplex virus, VZV varicella zoster virus, CMV cytomegalovirus, ESR erythrocyte sedimentation rate, FBS fasting blood sugar, AST aspartate aminotransferase, ALT alanine aminotransferase, BUN blood urea nitrogen, GFR glomerular filtration rate, n/a not applicable
Table 4
Association between the presence CMV DNA in aqueous and corneal endothelial cell count in patients with anterior hypertensive uveitis
 
Model 1
Model 2
Model 3
Unadjusted
Adjusted for age and gender
Adjusted for age, gender, lens status, and history of glaucoma surgery
B (CI)
B (CI)
B (CI)
CMV positivity
672.4
734.4
1034.2
 
(77.0–1267.9)
(116.4–1352.4)
(631.3–1437.1)
P value
0.029
0.023
<0.001
B beta coefficient, CI confidence interval

Case reports

Patient 1

A 68-year-old man had hypertensive anterior uveitis of his left eye with a recurrence rate of one to two times a month since 2010. On slit-lamp examination at Seoul St. Mary’s Hospital in October 2012, fine KPs in the lower part of the cornea and mild inflammatory reaction in the anterior chamber were seen. The corneal endothelial cell count of the left eye was 2141 cells/mm2, and the IOP was 22 mmHg with two topical antiglaucoma medications. He showed glaucomatous optic disc changes, with a mean deviation of −9.50 dB. Despite the use of topical steroids and three antiglaucoma medications for 5 months, his IOP was not controlled, and his corneal endothelial cell count in the left eye decreased to 1245 cells/mm2. A CMV-quantitative PCR analysis of aqueous humor samples for the left eye revealed 229,000 copies/mL CMV-DNA, but no HSV-DNA. Thus, an oral course of valacyclovir (90 mg/day) was started. The ExPRESS glaucoma filtration device (P-200) was implanted under a scleral flap. Oral valacyclovir (900 mg/day) was continued for 10 days, and anterior chamber tapping revealed 66,600 copies/mL CMV-DNA. Oral valacyclovir treatment (450 mg/day) was continued for another 14 days, and repeated anterior chamber tapping revealed 630 copies/mL CMV-DNA. After glaucoma surgery, the anterior chamber had a rare to +1 grade inflammation, and IOP was well controlled in a range of 6–9 mmHg. However, 5 months later, his corneal endothelial cell count was found to have decreased further, to 981 cells/mm2 (Fig. 1).

Patient 2

A 64-year-old man had hypertensive anterior uveitis of his left eye with a recurrence rate of one to two times a month since 1991. He had been diagnosed with Posner-Schlossman syndrome, but chronic inflammation in the anterior chamber with uncontrolled IOP elevation was seen, and he was referred to Seoul St. Mary’s Hospital for glaucoma surgery. At the initial visit, mutton-fat keratic precipitates were noted in the central cornea with minimal anterior chamber reaction (Fig. 2). IOP was 21 mmHg with three antiglaucoma medications, and high pigmentation was noted in the anterior chamber angle. Severe glaucomatous optic disc was seen, with a mean deviation of −18.20 dB. The corneal endothelial cell count of the left eye was 1310 cells /mm2. A CMV-quantitative PCR analysis of an aqueous humor sample for the left eye revealed 44,609 copies/mL CMV-DNA, but no HSV-DNA. Oral valacyclovir treatment (900 mg/day) was started, and an Ahmed glaucoma valve was implanted. After 14 days of oral valacyclovir treatment, the aqueous humor showed 6980 copies/mL CMV-DNA. Oral valacyclovir was continued for 14 days, and further anterior chamber tapping showed 450 copies/mL CMV-DNA. After 1 month, the corneal endothelial cell count of the left eye was 1310 cells/mm2.

Discussions

We reported the clinical characteristics of hypertensive anterior uveitis (Table 1), which occurred unilaterally (93 %), predominantly in middle-aged (57.6 ± 17.0 years) males (69.0 %; Table 1). Despite seemingly mild intraocular inflammation of the anterior chamber in the majority of patients (88.1 %) and the absence of peripheral anterior synechiae (0 %), glaucoma surgeries were required in over half of the patients (52.4 %). The male dominance in hypertensive anterior uveitis is consistent with previous results in non-Korean populations [4, 7]. Among the patients who underwent aqueous sampling, six (28.6 %) patients were positive for CMV-DNA. This prevalence is similar to the previous studies, reporting 22.8 % of anterior uveitis associated with raised IOP [1, 4].
Notably, the corneal endothelial cell count in the CMV-positive subjects was significantly lower than in the CMV-negative subjects (P = 0.009; Table 2). This association between the presence of CMV-DNA and the corneal endothelial cell count was more evident after adjusting for age, gender, lens status, and history of glaucoma surgery (P < 0.001; Table 3). Previous studies demonstrated that CMV is an important pathogen for chronic corneal endotheliitis, particularly in Asian populations [79, 13]. This study confirmed that CMV is a major cause of corneal endothelial cell loss in patients with hypertensive anterior uveitis.
Evidence of valacyclovir’s efficacy was seen in our study, using serial follow-up of CMV-DNA copy number and corneal endothelial cell counts in two case patients. After 1 month of therapy, CMV-DNA copy numbers decreased dramatically in both patients. Considering that patient 1 showed very high CMV-DNA copy numbers (44,609 copies/mL), it seems that one episode of acutely increased viral load is sufficient to cause extensive corneal endothelial cell loss. Consistent with our study, Kandori et al. [11] also reported a significant correlation between CMV viral load and corneal endothelial cell loss in CMV-associated uveitis.
We found that the proportion of monocytes tended to be lower in CMV-positive subjects, with marginal significance (P = 0.053; Table 2). Monocytes are the primary cell type of CMV persistence within the peripheral blood mononuclear cells [14]. CMV infection of monocytes induces trans-endothelial migration and monocyte to macrophage differentiation, which is productive for CMV replication [15]. Although the reason is unclear, CMV-induced differentiation of monocytes into macrophages may be associated with the lower proportion of monocytes in CMV-positive subjects in this study.
We found that the CMV-positive subjects were significantly younger (P = 0.006, Table 2). Generally, CMV seropositivity increases with age and serves as an immune risk phenotype, which is associated with survival in an older population [16, 17]. The current understanding of the mechanisms by which CMV reactivates in relatively young immunocompetent subjects is very limited. CMV is unlikely to cause clinically significant symptoms as long as it is maintained in balance by the host immune system [18]. However, recent literature suggests that CMV is associated with the pathogenesis of cardiovascular diseases, such as atherosclerosis, autoimmune disease, and even certain cancers [19, 20]. It is known that CMV can be reactivated when circulating monocytes with latent CMV are recruited to sites of inflammation [20]. For this reactivation, inflammatory cytokines, such as tumor necrosis factor and interferon, are known to play a role [21, 22]. In this regard, it is suggested that chronic inflammation in the anterior chamber may trigger CMV reactivation, which in turn, aggravates the inflammatory condition. In addition, CMV anterior uveitis is recalcitrant to topical steroid treatment [3, 4]. Recent reports show evidence that local immunosuppression by topical steroid use increases the risk of CMV infection in immunocompetent patients [2326]. In addition, there is possibility that the frequent use of prostaglandin eyedrops have play an important role for worsening, including the uncontrolled glaucoma, considering previous reports regarding the complications from glaucoma eyedrops in uveitis [2729].

Conclusions

In conclusion, we found that CMV was a significant etiological factor in hypertensive anterior uveitis patients in Korea. In CMV-associated uveitis, extensive corneal endothelial cell damage may occur, even with effective anti-viral medication. CMV-associated hypertensive anterior uveitis patients were younger compared to CMV-negative uveitis patients. Special caution is needed for patients with CMV-positive hypertensive anterior uveitis, given its adverse effects on the corneal endothelium.

Acknowledgements

Not applicable.

Funding

The authors wish to acknowledge of the financial support of the National Research Foundation of Korea Grant funded by the Korean government (MSIP) (No. NRF- 2016R1C1B1011287).

Authors’ contributions

JAC and CKP contributed to the conception and design. JAC, KSK, and YHJ contributed to the acquisition of data and analysis and interpretation of data. JAC contributed in drafting the manuscript. HYLP contributed in revising the manuscript. CKP gave the final approval of the version to be published. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Ethics approval

The study protocol was approved by the institutional review/ethics boards of Seoul St. Mary’s Hospital, the Catholic University of Korea (IRB number: KC14RISI0513).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
1.
Zurück zum Zitat Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840CrossRefPubMed Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840CrossRefPubMed
2.
Zurück zum Zitat van Boxtel LA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358–1362CrossRefPubMed van Boxtel LA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358–1362CrossRefPubMed
3.
Zurück zum Zitat Jap A, Chee SP (2010) Emerging forms of viral uveitis in the developing world. Int Ophthalmol Clin 50:155–171CrossRefPubMed Jap A, Chee SP (2010) Emerging forms of viral uveitis in the developing world. Int Ophthalmol Clin 50:155–171CrossRefPubMed
5.
Zurück zum Zitat Park SW, Yu HG (2013) Association of cytomegalovirus with idiopathic chronic anterior uveitis with ocular hypertension in Korean patients. Ocul Immunol Inflamm 21:192–196CrossRefPubMed Park SW, Yu HG (2013) Association of cytomegalovirus with idiopathic chronic anterior uveitis with ocular hypertension in Korean patients. Ocul Immunol Inflamm 21:192–196CrossRefPubMed
6.
Zurück zum Zitat Knox DL (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 146:625, author reply 625-626CrossRefPubMed Knox DL (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 146:625, author reply 625-626CrossRefPubMed
7.
Zurück zum Zitat Koizumi N, Inatomi T, Suzuki T et al (2015) Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol 99:54–58CrossRefPubMed Koizumi N, Inatomi T, Suzuki T et al (2015) Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol 99:54–58CrossRefPubMed
8.
Zurück zum Zitat Kobayashi A, Yokogawa H, Higashide T, Nitta K, Sugiyama K (2012) Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. Am J Ophthalmol 153:445–453CrossRefPubMed Kobayashi A, Yokogawa H, Higashide T, Nitta K, Sugiyama K (2012) Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. Am J Ophthalmol 153:445–453CrossRefPubMed
9.
Zurück zum Zitat Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2007) Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 114:798–803CrossRefPubMed Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2007) Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 114:798–803CrossRefPubMed
10.
Zurück zum Zitat Sungur GK, Hazirolan D, Yalvac IS, Ozer PA, Aslan BS, Duman S (2010) Incidence and prognosis of ocular hypertension secondary to viral uveitis. Int Ophthalmol 30:191–194CrossRefPubMed Sungur GK, Hazirolan D, Yalvac IS, Ozer PA, Aslan BS, Duman S (2010) Incidence and prognosis of ocular hypertension secondary to viral uveitis. Int Ophthalmol 30:191–194CrossRefPubMed
11.
Zurück zum Zitat Kandori M, Miyazaki D, Yakura K, Komatsu N, Touge C, Ishikura R, Inoue Y (2013) Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol 57(6):497–502 Kandori M, Miyazaki D, Yakura K, Komatsu N, Touge C, Ishikura R, Inoue Y (2013) Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol 57(6):497–502
13.
Zurück zum Zitat Chee SP, Jap A (2011) Immune ring formation associated with cytomegalovirus endotheliitis. Am J Ophthalmol 152:449–453, e441CrossRefPubMed Chee SP, Jap A (2011) Immune ring formation associated with cytomegalovirus endotheliitis. Am J Ophthalmol 152:449–453, e441CrossRefPubMed
14.
Zurück zum Zitat Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059–2064CrossRefPubMed Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059–2064CrossRefPubMed
15.
Zurück zum Zitat Smith MS, Bentz GL, Alexander JS, Yurochko AD (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 78:4444–4453CrossRefPubMedPubMedCentral Smith MS, Bentz GL, Alexander JS, Yurochko AD (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 78:4444–4453CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445–453CrossRefPubMed Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445–453CrossRefPubMed
18.
Zurück zum Zitat Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102:4140–4145CrossRefPubMedPubMedCentral Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102:4140–4145CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218–223CrossRefPubMed Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218–223CrossRefPubMed
21.
Zurück zum Zitat Prösch S, Heine AK, Volk HD, Krüger DH (2001) CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem 276:40712–40720CrossRefPubMed Prösch S, Heine AK, Volk HD, Krüger DH (2001) CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem 276:40712–40720CrossRefPubMed
22.
Zurück zum Zitat Prösch S, Staak K, Stein J et al (1995) Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 208:197–206CrossRefPubMed Prösch S, Staak K, Stein J et al (1995) Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 208:197–206CrossRefPubMed
23.
Zurück zum Zitat Sims JL, Chee SP (2010) Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant. Eye (Lond) 24:197–198CrossRef Sims JL, Chee SP (2010) Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant. Eye (Lond) 24:197–198CrossRef
24.
Zurück zum Zitat Tugal-Tutkun I, Araz B, Cagatay A (2010) CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis. Int Ophthalmol 30:591–593CrossRefPubMed Tugal-Tutkun I, Araz B, Cagatay A (2010) CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis. Int Ophthalmol 30:591–593CrossRefPubMed
25.
Zurück zum Zitat Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol 143:334–335CrossRefPubMed Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol 143:334–335CrossRefPubMed
26.
Zurück zum Zitat Park UC, Kim SJ, Yu HG (2011) Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis. Ocul Immunol Inflamm 19:282–283CrossRefPubMed Park UC, Kim SJ, Yu HG (2011) Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis. Ocul Immunol Inflamm 19:282–283CrossRefPubMed
27.
Zurück zum Zitat Goyal R, Ram AR (2000) Brimonidine tartarate 0.2 % (Alphagan) associated granulomatous anterior uveitis. Eye (Lond) 14:908–910CrossRef Goyal R, Ram AR (2000) Brimonidine tartarate 0.2 % (Alphagan) associated granulomatous anterior uveitis. Eye (Lond) 14:908–910CrossRef
28.
Zurück zum Zitat Cates CA, Jeffrey MN (2003) Granulomatous anterior uveitis associated with 0.2 % topical brimonidine. Eye (Lond) 17:670–671CrossRef Cates CA, Jeffrey MN (2003) Granulomatous anterior uveitis associated with 0.2 % topical brimonidine. Eye (Lond) 17:670–671CrossRef
29.
Zurück zum Zitat Warwar RE, Bullock JD, Ballal D (1998) Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 105:263–268CrossRefPubMed Warwar RE, Bullock JD, Ballal D (1998) Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 105:263–268CrossRefPubMed
Metadaten
Titel
Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients
verfasst von
Jin A Choi
Kyu Seop Kim
Younhea Jung
Hae Young Lopilly Park
Chan Kee Park
Publikationsdatum
01.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Ophthalmic Inflammation and Infection / Ausgabe 1/2016
Elektronische ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-016-0100-5

Weitere Artikel der Ausgabe 1/2016

Journal of Ophthalmic Inflammation and Infection 1/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.